Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

7.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

781
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
781
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.2K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.2K
T Cell Types and Functions01:24

T Cell Types and Functions

1.6K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

[Otitis media - update on clinical presentation, diagnosis and therapy].

Laryngo- rhino- otologie·2026
Same author

Dynamics of the Interleukin-10 Family of Cytokines in Chronic Otitis Media Patients upon 1,8-Cineol Treatment.

In vivo (Athens, Greece)·2026
Same author

Precise ablation of cholesteatoma using a 445-nm diode laser.

Scientific reports·2026
Same author

Enhancing the Efficacy of Noncontact Laser Ablation of Weakly Absorbing Cholesteatoma Tissue Using a Blood Layer.

Lasers in surgery and medicine·2026
Same author

Quality of life in children with active middle ear implants: A Scoping Review.

Laryngo- rhino- otologie·2026
Same author

Polygenic Contribution to Sensorineural Hearing Loss Implicates Novel Risk Loci and Convergence with Congenital Hearing Loss Genes.

Journal of the Association for Research in Otolaryngology : JARO·2026
Same journal

Laryngo- rhino- otologie·2026
Same journal

Laryngo- rhino- otologie·2026
Same journal

Laryngo- rhino- otologie·2026
Same journal

[Diagnostic error "acute otitis media"].

Laryngo- rhino- otologie·2026
Same journal

[Pharyngeal high‑resolution manometry: techniques and applications].

Laryngo- rhino- otologie·2026
See all related articles

Related Experiment Video

Updated: Oct 29, 2025

Endoscopic Cholesteatoma Surgery
08:47

Endoscopic Cholesteatoma Surgery

Published on: January 19, 2022

11.3K

[Immunomodulation in Cholesteatoma].

Anke Leichtle1, David Leffers1, Markus Georg Daerr1

  • 1Klinik und Poliklinik für Hals-, Nasen- und Ohrenheilkunde, Universitätsklinikum Schleswig-Holstein Campus - Lübeck HNO Klinik, Lübeck, Germany.

Laryngo- Rhino- Otologie
|July 7, 2021
PubMed
Summary
This summary is machine-generated.

Cholesteatoma growth is immunomodulatory regulated, with tumor necrosis factor (TNF) playing a key role. Targeting TNF may offer a new therapeutic approach for cholesteatoma.

More Related Videos

Robot-Assisted Transcanal Endoscopic Ear Surgery for Congenital Cholesteatoma
02:37

Robot-Assisted Transcanal Endoscopic Ear Surgery for Congenital Cholesteatoma

Published on: December 15, 2023

975
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

873

Related Experiment Videos

Last Updated: Oct 29, 2025

Endoscopic Cholesteatoma Surgery
08:47

Endoscopic Cholesteatoma Surgery

Published on: January 19, 2022

11.3K
Robot-Assisted Transcanal Endoscopic Ear Surgery for Congenital Cholesteatoma
02:37

Robot-Assisted Transcanal Endoscopic Ear Surgery for Congenital Cholesteatoma

Published on: December 15, 2023

975
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

873

Area of Science:

  • Immunology
  • Otolaryngology
  • Molecular Biology

Background:

  • The exact causes of chronic otitis media epitympanalis/cholesteatoma and its destructive progression remain unclear.
  • Complications include hearing loss, vestibular dysfunction, facial nerve paralysis, and intracranial issues.
  • Research is increasingly focusing on the innate immune system's role.

Purpose of the Study:

  • To investigate the immunomodulatory mechanisms underlying cholesteatoma.
  • To evaluate Tumor Necrosis Factor (TNF) as a potential therapeutic target.

Main Methods:

  • Studies utilized wild-type (WT) and immunodeficient knockout (KO) mouse models.
  • Gene and protein expression analyses were performed on cholesteatoma and healthy ear tissues.
  • Apoptosis levels were assessed using TUNEL staining and immunohistochemistry, with TNF as a primary target.

Main Results:

  • Uncontrolled cholesteatoma growth exhibits an immunomodulatory profile with altered gene networks, particularly in TNF signaling pathways.
  • TNF expression in cholesteatoma is modulated both inflammatorily and apoptotically.
  • These findings suggest TNF's suitability as a therapeutic target.

Conclusions:

  • Cholesteatoma may be regulated by immunomodulatory processes.
  • TNF modulation presents a potential therapeutic avenue for cholesteatoma treatment.